monoclonal gpsn2 antibody clinical trial

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
monoclonal gpsn2 antibody clinical trial	0.29	1	9152	37	40
monoclonal	0.46	0.6	2480	56	10
gpsn2	0.49	0.2	7275	5	5
antibody	0.29	0.5	2849	100	8
clinical	1.61	0.6	9342	15	8
trial	0.51	0.6	2086	16	5

Keyword	CPC	PCC	Volume	Score
monoclonal gpsn2 antibody clinical trial	1.5	0.8	7518	35
monoclonal gpsn2 antibody therapy	0.36	0.1	3694	71
monoclonal gpsn2 antibody development	1.3	0.9	9570	41
monoclonal gpsn2 antibody production	1.44	0.7	8185	92
monoclonal gpsn2 antibody function	0.5	1	9658	42
monoclonal gpsn2 antibody target	0.35	0.6	7002	8
monoclonal gpsn2 antibody mechanism of action	1.33	0.3	8568	20
monoclonal gpsn2 antibody structure	1.4	0.7	9450	48
monoclonal gpsn2 antibody drug conjugate	1.26	0.1	9349	53
monoclonal antibody gpr18 clinical trials	1.59	1	8001	22
smn1 monoclonal antibody clinical trial	0.25	0.6	7631	73
monoclonal gnl1 antibody therapy	1.33	0.1	4230	22
monoclonal gnl1 antibody research	1.52	0.5	4818	70
monoclonal antibodies clinical trials	1.36	0.1	4658	34
monoclonal gnl1 antibody applications	1.04	0.9	3566	89
monoclonal hgf antibody clinical trial	0.52	0.3	7327	15
monoclonal gnl1 antibody detection	0.84	0.7	6509	22
monoclonal ndfip1 antibody clinical trials	1.95	0.8	3246	75
monoclonal gnl1 antibody test	0.79	0.2	8427	53
monoclonal gnl1 antibody production	1.33	0.5	9869	98
monoclonal antibody melanoma clinical trials	0.66	0.3	2326	92
gcn2 inhibitor clinical trial	1.98	0.3	8514	85
monoclonal gnl1 antibody development	0.55	0.9	1526	14
monoclonal gnl1 antibody engineering	0.93	0.3	2952	96